|
Market Closed -
Hong Kong S.E.
01:38:33 28/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.955 HKD | +0.26% |
|
+0.26% | -56.94% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 609.6 | - | - |
| Change | - | -30.05% | -30.06% | -58.88% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 678.3 | 609.6 | 447.9 |
| Change | - | -16.83% | -28.53% | -53.81% | -10.13% | -26.52% |
| P/E | -1.04x | -4.72x | -3.96x | -3.66x | 12.9x | 1.62x |
| PBR | 2.25x | 2.17x | 1.52x | 1.32x | 1.2x | 0.87x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 0.94x | 0.52x | 0.35x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.05x | 0.52x | 0.26x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -5.71x | 7.47x | 1.01x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -4.73x | 11.5x | 1.84x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -2.21x | -21.6x | 7.27x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -45.2% | -4.63% | 13.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 1.678 | 1.678 | 1.678 |
| Nbr of stocks (in thousands) | 3,04,024 | 3,18,588 | 3,63,368 | 3,63,368 | - | - |
| Announcement Date | 27/03/24 | 24/03/25 | 24/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.66x | 1.05x | -5.71x | - | 9.06Cr | |
| 33.44x | 12.14x | 24.6x | 0.59% | 1,04700Cr | |
| 29.82x | - | - | 2% | 65TCr | |
| 32.61x | 7.57x | 15.74x | 2.68% | 45TCr | |
| 19.99x | 4.75x | 11.76x | 2.79% | 35TCr | |
| 21.76x | 5.62x | 13.93x | 2.85% | 29TCr | |
| 20.88x | 4.29x | 12.24x | 2.06% | 25TCr | |
| 27.35x | 7.07x | 12.56x | 2.33% | 23TCr | |
| 13.25x | 4.77x | 9.95x | 3.83% | 20TCr | |
| -44.51x | 6.43x | 25.11x | 2.26% | 18TCr | |
| Average | 15.09x | 5.96x | 13.35x | 2.38% | 36.59TCr | |
| Weighted average by Cap. | 24.24x | 8.07x | 17.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
